From New York to Toronto: the 500-mile walk that raised $750,000 for Parkinson’s research
Author: Parkinson's Life editorsPublished: 14 July 2016
Prep: Cook: Serves:
When three friends embarked on an epic 500-mile journey on foot from New York City to Toronto, they weren’t expecting the hiker who inspired the walk to travel all the way from Scotland to show his support and join them for the final leg
Five hundred miles is a long distance for anyone to walk – and it’s even more of a challenge if you’re battling Parkinson’s symptoms all the way. Yet that’s exactly what three friends – Harry McMurtry, Sue Thompson and Ross Sugar – did when they set out on a remarkable journey from New York City, US, to Harry’s hometown Toronto, Canada.
“It took all the strength I could summon to finish the walk each day, but I wouldn’t quit,” said Harry, a former lawyer who was diagnosed with early-onset Parkinson’s in 2009. “Too many people were counting on us.”
The walk, dubbed ‘500 Miles for Parkinson’s’, took nearly two months to complete, averaging 15 miles a day. The trio had set a fundraising target of $500,000. In the end, they raised a staggering total of $750,000.
The streets of Toronto were closed off by police to make way for the walk
“I would be lying if I didn’t say that this took every ounce of energy and strength I had to do this,” said Harry, who was taken to hospital when he fell during the challenging walk. “By the end, my body was ready to shut down. But I wanted to help people with Parkinson’s, so I never gave up.”
“By the end, my body was ready to shut down. But I wanted to help people with Parkinson’s, so I never gave up”
If crossing the finishing line was ever in the balance, Harry’s spirits must surely have been lifted by the many friends, relatives and celebrities who turned out to support him along the way – including a surprise trans-Atlantic visit from the man said to have inspired it all.
In 2014, John MacPhee walked the same distance on his ‘Long Straight Walk’ across England and Scotland (starting at Land’s End in Cornwall and ending at John O’Groats in the Scottish Highlands). While Harry was researching his own walk, he reached out to John for advice via the Internet – and the two became friends.
So when Harry’s support team contacted John to see if he’d come all the way from Scotland to join the last leg of the walk with Harry at the end of June, in a surprise ‘guest’ appearance, he didn’t hesitate.
John MacPhee dressed in a traditional Scottish kilt
John, from Inverness, told Parkinson’s Life: “As the end of Harry’s walk drew closer the organisers urged me to complete the walk with him – Harry’s support team was keen to keep my visit a surprise for him.”
Describing the scene as the pair met for the first time, John continued: “Harry was ready to start the penultimate walk of his epic 500-mile journey. When he saw me, a huge smile spread across his tanned face. I wasn’t quite ready for the enormous hug but I knew this was a very big surprise and judging by the tears that ran down both of our faces, it was an emotional moment.”
The three walkers and their supporters – including John – celebrated the success of the challenge at a huge fundraising gala in Toronto, which saw the auction of ice hockey shirts belonging to the famous Wayne Gretzky, raising a further US$10,000. The total sum exceeded $750,000.
Ice hockey player Wayne Gretzky’s jersey was auctioned off for $10,000
John paid tribute to the efforts of Harry and his companions: “The three walkers who made it every step of the way are giants. Harry McMurtry, Sue Thompson and Ross Sugar are real heroes.
“They proved you are most certainly not defined by this condition, you are defined by your excellence at being human beings, the people who surround you and support you are there because you make it real, you made it happen.”
500 miles for Parkinson’s proved to be a great success
Parkinson’s disease in three words – and other highlights of our Christmas special
What has Parkinson’s given you – and what has it taken away? This is just one of the questions to look out for in our podcast’s upcoming Christmas special. In this episode, we’ll bring together voices from across the podcast, as guests share their unique perspectives on three prompts about life with the condition: Describe Parkinson’s disease in three words. What gets you through the day? What has Parkinson’s given you – and what has it taken away? For many people, the start of a new year offers an opportunity for reflection – so as we look forward to this episode, we invite our readers to share their own answers to the questions above. If you’d like to share your answers with us, or if you’re interested in taking part in future episodes, get in touch through Facebook, Twitter or by emailing firstname.lastname@example.org. We look forward to hearing from you!
Wearable device for Parkinson’s disease raises $10m in funding
UK-based tech company Charco Neurotech has secured $10 million in seed investment funding to support the launch of a non-invasive wearable device designed for people with Parkinson’s disease. CUE1 is a circular device worn on the sternum, which is designed to help alleviate Parkinson’s symptoms through specialised vibrations that are personalised for each patient. The investment round, which was co-led by venture capital company Amadeus Capital Partners and growth fund managers Parkwalk Advisors, is the largest European seed financing in 2021 for a heath technology device – and the sixth largest globally. Lucy Jung, co-founder and CEO of Charco Neurotech, said: “This funding will enable us to proceed with our first, limited launch, while we work to ensure our manufacturing line is robust and produces consistent high quality devices.” Charco also recently announced a new partnership with the European Parkinson’s Disease Association (EPDA), to help increase the availability of Charco’s…
An international team led by the University of Ottawa in Canada will study whether the scent-processing nerves inside the nose may play a part in the development of Parkinson’s disease. The researchers will explore potential connections between inflammation, environmental exposures in the nasal cavity, odour processing centres in the brain and Parkinson’s-related genes. The scientists hope that if the study indicates that Parkinson’s starts in the nose, early signs of the condition could potentially be detected sooner. This research, which will use human and animal models, has been made possible by a US $9m grant from the Aligning Science Across Parkinson’s (ASAP) initiative, which aims to improve understanding of the causes of the condition. “This grant will allow us to explore an understudied but important aspect of Parkinson’s, which could lead to new approaches for early treatment and prevention,” said Professor Michael Schlossmacher, team leader of the study.